Avantor, Inc. (NYSE:AVTR) Receives $26.71 Consensus PT from Brokerages

Avantor, Inc. (NYSE:AVTR) has been given a consensus rating of “Moderate Buy” by the sixteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $26.71.

Several research firms recently issued reports on AVTR. Deutsche Bank Aktiengesellschaft upped their target price on Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a report on Thursday, April 18th. Citigroup upped their target price on Avantor from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Thursday, February 15th. Barclays upped their target price on Avantor from $27.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, April 10th. JPMorgan Chase & Co. upped their target price on Avantor from $26.00 to $29.00 and gave the stock an “overweight” rating in a report on Thursday, February 15th. Finally, Robert W. Baird upped their target price on Avantor from $25.00 to $26.00 and gave the stock an “outperform” rating in a report on Thursday, February 15th.

Avantor Stock Down 0.7 %

NYSE:AVTR opened at $25.46 on Friday. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 1.00. The stock has a market cap of $17.27 billion, a price-to-earnings ratio of 53.04, a PEG ratio of 2.48 and a beta of 1.37. The stock has a 50-day moving average price of $25.05 and a two-hundred day moving average price of $22.57. Avantor has a 1 year low of $16.63 and a 1 year high of $26.16.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.03. The company had revenue of $1.72 billion during the quarter, compared to analysts’ expectations of $1.70 billion. Avantor had a return on equity of 14.11% and a net margin of 4.61%. Avantor’s revenue for the quarter was down 4.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.32 earnings per share. As a group, equities analysts expect that Avantor will post 1.01 earnings per share for the current year.

Insider Transactions at Avantor

In other news, EVP James Bramwell sold 6,203 shares of the stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the transaction, the executive vice president now owns 101,143 shares in the company, valued at $2,476,992.07. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Avantor

Large investors have recently added to or reduced their stakes in the stock. Fifth Third Bancorp grew its position in Avantor by 125.3% during the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after buying an additional 694 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in shares of Avantor by 565.5% in the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock valued at $30,000 after purchasing an additional 1,131 shares in the last quarter. Gladius Capital Management LP acquired a new stake in shares of Avantor in the 4th quarter valued at $42,000. Montag A & Associates Inc. acquired a new stake in shares of Avantor in the 4th quarter valued at $43,000. Finally, TFO Wealth Partners LLC boosted its holdings in shares of Avantor by 203,100.0% in the 4th quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after purchasing an additional 2,031 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.